FDA Just Says "No" To Salk Immunogen.
The illustrious Dr. Jonas Salk and officials of his Immune Response Corp. appeared before an FDA advisory committee on 26 January seeking approval for large-scale Phase III efficacy trials of its envelope depleted HIV (Zairean strain) as a possible therapeutic vaccine. (The design was originally intended to be "whole-killed," but the envelope was accidentally depleted in the attenuation process, thus the current concept.) To their credit, the advisory panel judged the efficacy data to be extremely weak, and agreed that the Salk Immunogen failed to show enough promise to warrant Phase III studies.
Varmus Selects New Director for Office of Alternative Medicine. Lt. Colonel Wayne Jonas, of the Walter Reed Army Institute of Research, will replace out-going director Joseph Jacobs (who resigned last September) at the NIH's OAM effective July 1, 1995. Jonas has been a consultant on several OAM projects and has studied homeopathy, acupuncture, nutritional and megavitamin therapy and NMR spectroscopy. The Office of Alternative Medicine was created by Congress in 1992.
This article was provided by Treatment Action Group. It is a part of the publication TAGline.